BIOCHEMICAL MARKERS OF THREATENED MISCARRIAGE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To elaborate additional biochemical markers of threatened premature delivery. Subjects and method. The prospective investigation enrolled 52 patients with symptoms of threatened delivery. The diagnostic value of nonphosphorylated insulin-like growth factor-binding protein 1 (IGFBP-1) and interleukin-6 (IL-6) in the cervicovaginal secretion and that of progesterone and estradiol in the saliva was evaluated by enzyme immunoassay. Results. Significant differences were found in IL-6 levels in patients who had given birth prematurely or timely. ROC analysis indicated that the optimal sensitivity and specificity (100.0 and 42.1%, respectively) were observed at an IL-6 level of 66.79 pg/ml. The prognostic value of positive and negative results was 38.9 and 100%, respectively. Examination of IGFBP-1 in the cervical secretion and estradiol and progesterone in the saliva revealed no significant differences in the patients who had given birth prematurely and timely. Conclusion. The cervical secretion IL-6 concentration of less than 66.7 pg/ml allows patients at low risk for premature birth to be identified with a high degree of accuracy.

Full Text

Restricted Access

About the authors

A. E KOVALENKO

M.V. Lomonosov Moscow University

Email: acromion19847@mail.ru

N. N KALININA

M.V. Lomonosov Moscow University

Email: n_i_kalinina@mail.ru

M. V ALEKSEENKOVA

M.V. Lomonosov Moscow University

O. B PANINA

M.V. Lomonosov Moscow University

Email: olgapanina@yandex.ru

G. M SAVELYEVA

M.V. Lomonosov Moscow University

References

  1. Berco P., Joubert K. The effect of intrauterine development and nutritional status on perinatal (intrauterine and neonatal) mortality. In: VIII FIGO World congress of gynecology and obstetrics: Abstract book. Kuala Lumpur, Malaysia; 2006: 58-9.
  2. Шалина Р.И., Плеханова Е.Р. Комплексная терапия беременных с угрозой преждевременных родов. Вопросы гинекологии, акушерства и перинатологии. 2007; 1: 33-40.
  3. Hassan S.S., Romero R., Vidyadhari D., Fusey S. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet. Gynecol. 2011; 38(1): 18-31.
  4. Matijevic R., Grgic O. Is sonographic assessment of cervical length better than digital examination in screening for preterm delivery in a low-risk population? Acta Obstet. Gynecol. Scand. 2006; 85(11): 1342-7.
  5. Ness A., Visintine J., Ricci E., Berghella V. Does knowledge of cervical length and fetal fibronectin affect management of women with threatened preterm labor? A randomized trial. Am. J. Obstet. Gynecol. 2007; 197(4): 426; e1-7.
  6. Ness A., Blumenfeld Y., Sung J.F. Preterm labor. In: Berghella V., ed. Preterm birth. Prevention and management. Wiley-Blackwell; 2010: 198-216.
  7. French N.P., Hagan R., Evans S.F., Godfrey M., Newnham J.P. Repeated antenatal corticosteroids: size at birth and subsequent development. Am. J. Obstet. Gynecol. 1999; 180(1, Pt 1): 114-21.
  8. Modi N., Lewis H., Al-Naqeeb N., Ajayi-Obe M., Dore C.J., Rutherford M. The effects of repeated antenatal glucocorticoid therapy on the developing brain. Pediatr. Res. 2001; 50: 581-5.
  9. Tsoi E., Fuchs I.B., Rane S., Geerts L., Nicolaides K.H. Sonographic measurement of cervical length in threatened preterm labor in singleton pregnancies with intact membranes. Ultrasound Obstet. Gynecol. 2005; 25(4): 353-6.
  10. Goldenberg R.L., Mercer B.M., Meis P.J., Copper R.L., Das A., McNellis D. for NICHD Maternal Fetal Medicine Units Network. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. Obstet. Gynecol. 1996; 87(5, Pt 1): 643-8.
  11. Sunagawa S., Takagi K., Ono K., Miyachi K., Kikuchi A. Comparison of biochemical markers and cervical length for predicting preterm delivery. J. Obstet. Gynaecol. Res. 2008; 34(5): 812-9.
  12. Vogel I., Thorsen P., Curry A., Sandager P., Uldbjerg N. Biomarkers for the prediction of preterm delivery. Acta Obstet. Gynecol. Scand. 2005: 84: 516-25.
  13. Leung T.N., Chung T.K., Madsen G., McLean M., Chang A.M., Smith R. Elevated mid-trimester maternal corticotrophin-releasing hormone levels in pregnancies that delivered before 34 weeks. Br. J. Obstet. Gynaecol. 1999; 106(10): 1041-6.
  14. Панина О.Б., Коваленко А.Е., Сичинава Л.Г., Клименко П.А., Алексеенкова М.В., Евтеев В.Б., Даллакян М.Г. Угроза преждевременных родов: верификация диагноза. Вопросы гинекологии, акушерства и перинатологии. 2012; 11(3): 26-30.
  15. Berghella V., ed. Preterm birth. Prevention and management. Wiley-Blackwell; 2010. 304p.
  16. Arechavaleta-Velasco F., Ogando D., Parry S., Vadillo-Ortega F. Production of matrix metalloproteinase-9 in lipopolysaccharide-stimulated human amnion occurs through an autocrine and paracrine proinflammatory cytokine-dependent system. Biol. Reprod. 2002; 67(6): 1952-8.
  17. Lockwood C.J., Arcuri F., Toti P., Felice C.D., Krikun G., Guller S. et al. Tumor necrosis factor-alpha and interleukin-1beta regulate interleukin-8 expression in third trimester decidual cells: implications for the genesis of chorioamnionitis. Am. J. Pathol. 2006; 169(4): 1294-302.
  18. Vogel I., Gr0nbaek H., Thorsen P., Flyvbjerg A. Insulin-like growth factor binding protein 1 (IGFBP-1) in vaginal fluid in pregnancy. In Vivo. 2004; 18(1): 37-41.
  19. Lachelin G.C.L., McGarrigle H.H.G., Seed P.T., Briley A., Shennan A.H., Poston L. Low saliva progesterone concentrations are associated with spontaneous early preterm labour (before 34 weeks of gestation) in women at increased risk of preterm delivery. Br. J. Obstet. Gynaecol. 2009; 116(11): 1515-9.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2013 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies